Business Numinus ends fiscal year with revenue up 72% to $1.5M, losses of $19M The psychedelics firm has been aggressively expanding lab space while pushing ahead with clinical trials Natalia Buendia CalvilloDecember 10, 2021
Cannabis Consuming cannabis while on psychedelics makes the experience stronger, researchers say Cannabis and 'classical' psychedelics could act on similar receptors Natalia Buendia CalvilloNovember 4, 2021
Policy Positions of NIH, FDA signal we’re ‘on the brink of a psychedelic revolution’ The psychedelic movement is no longer about anecdotes, experts say Natalia Buendia CalvilloJune 25, 2021
News California Senate passes psychedelic decriminalization bill If Bill SB-519 passes, possession of psychedelics for personal would be decriminalized, but cultivation and sale is still outlawed Natalia Buendia CalvilloJune 2, 2021
Medical and Pharmaceutical LSD could be used to treat people with autism, study suggests Early evidence shows LSD promotes social behaviour in rodents, but pharmaceutical research is still a ways off Natalia Buendia CalvilloMarch 1, 2021
Medical and Pharmaceutical Nature amplifies therapeutic effects of psychedelics: study A recent review suggests natural settings and activities can complement all stages of psychedelic-assisted therapy Natalia Buendia CalvilloFebruary 23, 2021
Canada Proposed amendment could greatly expand access to psychedelic therapy in Canada Proposed by Health Canada, the change would allow patients to access restricted substances like MDMA through the Special Access Program Natalia Buendia CalvilloJanuary 28, 2021
Health and Safety Could microdosing psychedelics help treat schizophrenia? Science doesn't know yet, but one psychedelic researcher is chasing clues to see if it can Michelle GamageSeptember 23, 2020